menu
    • menu
    [{"orgOrder":0,"company":"Northern Antibiotics","sponsor":"Prokaryotics","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"FINLAND","productType":"Antibiotic","year":"2025","type":"Licensing Agreement","leadProduct":"Spr 741","moa":"Bacterial outer membrane protein","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Northern Antibiotics","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Northern Antibiotics \/ Prokaryotics","highestDevelopmentStatusID":"6","companyTruncated":"Northern Antibiotics \/ Prokaryotics"}]

    Find Clinical Drug Pipeline Developments & Deals for Spr 741

    Menu

    Spr 741

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Northern Antibiotics

                            Country arrow
                            CAMX
                            Not Confirmed

                            Northern Antibiotics

                            Country arrow
                            CAMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Spr 741

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Sponsor : Prokaryotics

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Prokaryotics Announces Licensing Agreement with Northern Antibiotics

                            Details : Prokaryotics gains worldwide rights to develop, manufacture and commercialize the Gram-negative antibiotic potentiator NAB741 (previously known as SPR741).

                            Product Name : NAB741

                            Product Type : Antibiotic

                            Upfront Cash : Undisclosed

                            June 26, 2025

                            Lead Product(s) : Spr 741

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Sponsor : Prokaryotics

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Spero Therapeutics

                            U.S.A arrow
                            CAMX
                            Not Confirmed

                            Spero Therapeutics

                            U.S.A arrow
                            CAMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Spr 741

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Simbec Research | QPS Holdings

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            December 18, 2017

                            Lead Product(s) : Spr 741

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Simbec Research | QPS Holdings

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Spero Therapeutics

                            U.S.A arrow
                            CAMX
                            Not Confirmed

                            Spero Therapeutics

                            U.S.A arrow
                            CAMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Spr 741

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : CPR Pharma Services

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunt...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            January 16, 2017

                            Lead Product(s) : Spr 741

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : CPR Pharma Services

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth